1. Welcome to Baptist Board, a friendly forum to discuss the Baptist Faith in a friendly surrounding.

    Your voice is missing! You will need to register to get access to all the features that our community has to offer.

    We hope to see you as a part of our community soon and God Bless!

Johnson & Johnson's Coronavirus Vaccine Candidate Begins Human Testing

Discussion in 'News & Current Events' started by InTheLight, Jul 31, 2020 at 12:25 PM.

  1. InTheLight

    InTheLight Well-Known Member
    Site Supporter

    Joined:
    Dec 17, 2010
    Messages:
    24,792
    Likes Received:
    2,221
    Faith:
    Baptist
    Johnson & Johnson (NYSE:JNJ) has gained some ground in the coronavirus vaccine race. On Thursday, the pharmaceutical and consumer goods company announced that in pre-clinical studies, its Ad26.COV2-S vaccine candidate had demonstrated effectiveness in protecting on non-human primates from infection with SARS-CoV-2.

    In contrast to other coronavirus vaccine candidates -- such as the one many observers view as the most promising, Moderna's mRNA-1273 -- Johnson & Johnson's produced its response with a single dose.

    Based on those results, Johnson & Johnson has begun testing its candidate on humans in phase 1/2a clinical trials in the U.S. and Belgium. More than 1,000 healthy adults between the ages of 18 and 55, plus a cohort 65 and older, will participate in the trials. The company is also planning to conduct a phase 2a trial in the Netherlands, Spain, and Germany, and a phase 1 study in Japan.

    Johnson & Johnson's Coronavirus Vaccine Candidate Efficacious in Pre-Clinical Studies; Human Testing Has Begun | The Motley Fool
     
    • Informative Informative x 3
  2. KenH

    KenH Well-Known Member

    Joined:
    May 18, 2002
    Messages:
    34,985
    Likes Received:
    323
    Faith:
    Baptist
    Great news! Thanks for sharing.
     
Loading...